Clinical trial · Interventional
Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer
NCT01428739CI-TRIAL-00025629completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Correlation between MRS and Tumor Response Therapy in Breast Cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MRS | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- MRS Correlation with Treatment Response
- timeFrame
- Up to One Year
- description
- measuring choline, water and fat levels by proton magnetic resonance spectroscopy in breast tumors in response to treatment
Secondary outcomes (1)
- measure
- Correlation with Tumor Stage
- timeFrame
- Up to One year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically confirmed diagnosed Breast cancer * Patient is 18 years or older * Karnofsky performance score \> 70 * No previously irradiated or recurrent breast cancer * No contraindication to MRS/MRI * Signed informed consent.
References
Publications (0)
Data not yet available
No reference posted for this study.